Shares of Integral Ad Science Holding Corp. (NASDAQ:IAS – Get Free Report) have earned an average rating of “Moderate Buy” from the nine brokerages that are covering the firm, MarketBeat.com reports. Three research analysts have rated the stock with a hold recommendation and six have issued a buy recommendation on the company. The average twelve-month price target among brokers that have covered the stock in the last year is $15.06.
Several research firms have weighed in on IAS. Morgan Stanley reaffirmed a “mixed” rating on shares of Integral Ad Science in a report on Monday, March 3rd. Scotiabank began coverage on Integral Ad Science in a report on Friday, February 28th. They issued a “sector perform” rating and a $12.00 price target on the stock. Barclays reaffirmed an “equal weight” rating on shares of Integral Ad Science in a report on Friday, February 28th. Benchmark reaffirmed a “hold” rating on shares of Integral Ad Science in a report on Friday, February 28th. Finally, Truist Financial raised their price target on Integral Ad Science from $16.00 to $17.00 and gave the company a “buy” rating in a report on Monday, March 3rd.
Check Out Our Latest Analysis on IAS
Insiders Place Their Bets
Hedge Funds Weigh In On Integral Ad Science
A number of large investors have recently bought and sold shares of IAS. Oppenheimer & Co. Inc. purchased a new position in Integral Ad Science in the 3rd quarter worth approximately $281,000. Quest Partners LLC increased its stake in shares of Integral Ad Science by 101,255.9% during the third quarter. Quest Partners LLC now owns 34,461 shares of the company’s stock valued at $373,000 after buying an additional 34,427 shares during the period. Jennison Associates LLC purchased a new position in shares of Integral Ad Science during the third quarter valued at approximately $665,000. Intech Investment Management LLC purchased a new position in shares of Integral Ad Science during the third quarter valued at approximately $199,000. Finally, Charles Schwab Investment Management Inc. increased its stake in shares of Integral Ad Science by 7.5% during the third quarter. Charles Schwab Investment Management Inc. now owns 595,907 shares of the company’s stock valued at $6,442,000 after buying an additional 41,528 shares during the period. 95.78% of the stock is owned by hedge funds and other institutional investors.
Integral Ad Science Stock Down 1.0 %
Shares of NASDAQ IAS opened at $8.90 on Tuesday. Integral Ad Science has a 52 week low of $7.98 and a 52 week high of $13.62. The business has a 50-day simple moving average of $10.12 and a two-hundred day simple moving average of $10.63. The company has a quick ratio of 3.71, a current ratio of 3.71 and a debt-to-equity ratio of 0.07. The company has a market cap of $1.46 billion, a P/E ratio of 44.50, a P/E/G ratio of 1.06 and a beta of 1.45.
Integral Ad Science (NASDAQ:IAS – Get Free Report) last issued its earnings results on Friday, February 28th. The company reported $0.09 EPS for the quarter, missing the consensus estimate of $0.12 by ($0.03). Integral Ad Science had a return on equity of 3.47% and a net margin of 6.39%. The company had revenue of $153.00 million during the quarter, compared to the consensus estimate of $148.83 million. During the same quarter in the prior year, the business earned $0.06 EPS. The firm’s revenue for the quarter was up 13.9% compared to the same quarter last year. Research analysts anticipate that Integral Ad Science will post 0.26 earnings per share for the current fiscal year.
Integral Ad Science Company Profile
Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.
Recommended Stories
- Five stocks we like better than Integral Ad Science
- How to Capture the Benefits of Dividend Increases
- Why Williams-Sonoma Will Hit Fresh Highs in 2025
- What is Forex and How Does it Work?
- Alphabet Stock Becomes a Low-Risk, High-Reward Play
- How is Compound Interest Calculated?
- Affirm Stock: Should You Buy the Dip After Walmart Setback?
Receive News & Ratings for Integral Ad Science Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integral Ad Science and related companies with MarketBeat.com's FREE daily email newsletter.